| |
| |
|
| Insider
Information: |
Guindo Chirfi |
| Relationship: |
Chief Marketing Officer |
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
27,717 |
|
|
Indirect Shares
|
53 |
|
|
| Direct
Value |
$4,208,653 |
|
|
|
Indirect Value
|
$6,954 |
|
|
| Total
Shares |
27,770 |
|
|
| Total
Value |
$4,215,607 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Biogen Idec Inc |
BIIB |
Head of Glob Prod Stra... |
2022-02-18 |
7,364 |
2017-12-01 |
0 |
Premium* |
|
|
Merck & Co Inc |
MRK |
Chief Marketing Officer |
2023-08-03 |
20,353 |
2023-08-03 |
53 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| MRK |
Merck & Co Inc |
Chief Marketing Officer |
• • – |
2023-08-03 |
4 |
D |
$105.70 |
$1,901,437 |
D/D |
(17,989) |
20,353 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Chief Marketing Officer |
• • – |
2023-08-03 |
4 |
OE |
$105.70 |
$3,900,436 |
D/D |
36,901 |
38,342 |
0 |
- |
|
| MRK |
Merck & Co Inc |
Chief Marketing OfficerOfficer |
• – – |
2022-07-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
2 |
|
% |
|
| MRK |
Merck & Co Inc |
Chief Marketing OfficerOfficer |
• – – |
2022-07-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
50 |
|
% |
|
| MRK |
Merck & Co Inc |
Chief Marketing OfficerOfficer |
• – – |
2022-07-01 |
3/A |
IO |
$0.00 |
$0 |
D/D |
0 |
1,399 |
|
- |
|
| MRK |
Merck & Co Inc |
Chief Marketing OfficerOfficer |
• – – |
2022-07-01 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
50 |
|
- |
|
| BIIB |
Biogen Idec Inc |
Head of Glob Prod Strat & Com |
• • – |
2022-02-18 |
4 |
D |
$209.79 |
$184,405 |
D/D |
(879) |
7,364 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Glob Prod Strat & Com |
• • – |
2022-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,981 |
8,243 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Glob Prod Strat & Com |
• • – |
2022-02-12 |
4 |
D |
$214.59 |
$502,570 |
D/D |
(2,342) |
6,262 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Glob Prod Strat & Com |
• • – |
2022-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,597 |
8,044 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Glob Prod Strat & Com |
• • – |
2022-01-19 |
4 |
A |
$0.00 |
$0 |
D/D |
3,088 |
6,007 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
Head of Glob Prod Strat & Com |
• • – |
2021-06-07 |
4 |
AS |
$440.00 |
$1,358,280 |
D/D |
(3,087) |
2,919 |
0 |
% |
|
| BIIB |
Biogen Idec Inc |
EVP Glob. Prod Strat and Comm |
• • – |
2021-02-12 |
4 |
D |
$278.03 |
$261,348 |
D/D |
(940) |
6,006 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Glob. Prod Strat and Comm |
• • – |
2021-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,156 |
6,946 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Glob. Prod Strat and Comm |
• • – |
2020-12-01 |
4 |
D |
$243.16 |
$136,656 |
D/D |
(562) |
3,790 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Glob. Prod Strat and Comm |
• • – |
2020-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
481 |
4,004 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Glob. Prod Strat and Comm |
• • – |
2020-02-12 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,680 |
4,375 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Glob. Prod Strat and Comm |
• • – |
2020-02-12 |
4 |
D |
$331.76 |
$167,207 |
D/D |
(504) |
3,871 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Glob. Prod Strat and Comm |
• • – |
2019-12-01 |
4 |
D |
$299.81 |
$117,226 |
D/D |
(391) |
2,695 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Glob. Prod Strat and Comm |
• • – |
2019-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
543 |
2,855 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Glob. Mkt Acc & Cust Innov |
• • – |
2018-12-01 |
4 |
D |
$333.72 |
$136,491 |
D/D |
(409) |
2,543 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Glob. Mkt Acc & Cust Innov |
• • – |
2018-12-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
602 |
2,721 |
0 |
- |
|
| BIIB |
Biogen Idec Inc |
EVP Glob. Mkt Acc & Cust Innov |
• • – |
2017-12-01 |
4 |
A |
$0.00 |
$0 |
D/D |
2,350 |
2,350 |
0 |
- |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
